Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04239144
Other study ID # 49701215.2.0000.0068
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 9, 2018
Est. completion date March 9, 2026

Study information

Verified date May 2023
Source University of Sao Paulo General Hospital
Contact Paulo M Pego Fernandes, PhD
Phone +551126615921
Email paulo.fernandes@incor.usp.br
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Ventricular tachycardia (VT) is the main cause of sudden death in patients with structural heart diseases. The use of ICD (implantable cardio-defibrillator) could prevent sudden death, however, the occurrence of repetitive shock decreases significantly the quality of life and could increase the mortality rate. Chagas disease in our environment is the most common heart disease and often associated with the occurrence appropriate ICD therapies. The chronic treatment of VT aims to prevent recurrences with the use of antiarrhythmic drugs and catheter ablation, but in many cases, these treatments are insufficient to control the VT. Cardiac Sympathetic Denervation by bilateral sympathectomy has been described as an alternative treatment of VT refractory to medical treatment and radiofrequency ablation, especially in patients with channelopathies. This treatment could have a role in patients with structural heart disease. The objective of this study is to evaluate the efficacy of the bilateral sympathectomy in the reduction of ventricular tachycardia in patients with Chagas cardiomyopathy. In this pilot study, the investigators will select 45 patients with Chagas cardiomyopathy with ICD who presented at least four ICD therapies in the prior six months. These patients will be randomly assigned to three groups, 15 patients in medical therapy group, 15 in catheter ablation and 15 in bilateral sympathectomy.


Description:

OBJECTIVE Primary • Evaluate the efficacy of bilateral sympathectomy in the reduction of VT episodes in patients with Chagas cardiomyopathy. Secondary - To compare the efficacy of bilateral sympathectomy against VT ablation and against optimal medical therapy. - To evaluate the density of ventricular premature beats 24-hour Holter and monitor the events recorded by the ICD and the impact of the treatment performed. - To evaluate the length of the hospital stay according to the type of intervention. - To evaluate the rate of clinical complications according to the type of intervention. - To evaluate the impact of treatment on left ventricular function. Follow up Outcomes Assessment in six months and one year - Recurrence rate of appropriate therapies; - Density of ventricular ectopies; - Complication rates per type of intervention; - Number of in-hospital days per type of intervention; - Assessment of LV function; METHODS This is a pilot, single-centre, open-label, randomized trial in patients with Chagas disease and multiple appropriate ICD therapies. This study consists of three groups: (1) medical treatment, (2) catheter ablation and (3) bilateral sympathectomy, being included 15 patients in each group. Inclusion Criteria: - Patients with Chagas Disease Cardiomyopathy having an ICD - At least four appropriate ICD therapies in the past six months, documented by device interrogation or medical records; - Use of amiodarone and beta blockers in an optimized fashion; - Life expectancy of more than one year - Conditions for following the plan of clinical follow-up of the study. Exclusion criteria: - Presence of an absolute contraindication to receive any of the possible treatments of the study; - Pregnant Woman; - Less than 18 years-old; - Renal insufficiency with creatinine >2.5 mg/dL (221 umol/L); - Mobile thrombus in the left ventricle; - Left Ventricle Ejection fraction < 10%; - Unstable angina; - Severe aortic stenosis - Primary severe mitral insufficiency; - New York Heart Association (NYHA) functional class IV; - Previous cardiac surgery or scheduled. The patients will be recruited consecutively in the outpatient clinic of Cardiac Pacing Unit, or in outpatient clinic of Arrhythmias Clinical Unit or in the Emergency Clinical Unit. Group 1 - Medical Treatment: patients allocated to this group will receive amiodarone reimpregnation, incremental dose of beta-blocker and if possible ICD reprogramming. Group 2 - Catheter ablation: patients allocated to this group will undergo epicardial and endocardial catheter ablation with the use of an irrigated contact sensor tip catheter. Voltage electroanatomical mapping using Carto System will be performed in all cases and if hemodynamically stable VT is induced, activation mapping will also be performed. The aim of the ablation is to eliminate the clinical VT additionally to substrate modification. The result of ablation will be defined as (1) complete success (all VTs non-inducible); (2) partial success (clinical VT non inducible, but other morphologies still inducible) and (3) failure (clinical VT still inducible). Group 3 - Bilateral sympathectomy - bilateral sympathectomy will be performed using video assisted thoracoscopy using the Ethicon Ultracision device. The denervation consists of lower 1/3 stellate ganglion and T3- T4 thoracic interspinal space videothoracoscopic cutting, isolating the whole sympathetic chain between these two points using ultracision device on the nerve branches. The cephalic portion of the stellate ganglion will be preserved to avoid Horner's syndrome and the electrocautery use will also be avoided for the same reason. Hemodynamic and echocardiographic behaviors will be continuously monitored during these surgical maneuvers. After the application, 10 ml of 0.25% bupivacaine solution will be injected along the site of the pleural dissection for postoperative analgesia. The lung will be reinflated under direct vision and a small tube will be inserted to remove the air through the upper incision, which will be removed at the end of the operation if possible. The two port sites will be closed primarily with absorbable stitches. The study conformed to the principles outlined in the Declaration of Helsinki and was approved by the ethics committee and institutional review board of our hospital. All patients will provide written informed consent before randomization.


Recruitment information / eligibility

Status Recruiting
Enrollment 45
Est. completion date March 9, 2026
Est. primary completion date March 9, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients with Chagas Disease Cardiomyopathy having an ICD - At least four appropriate ICD therapies in the past six months, documented by device interrogation or medical records; - Use of amiodarone and beta blockers in an optimized fashion; - Life expectancy of more than one year - Conditions for following the plan of clinical follow-up of the study. Exclusion criteria: - Presence of an absolute contraindication to receive any of the possible treatments of the study; - Pregnant Woman; - Less than 18 years-old; - Renal insufficiency with creatinine >2.5 mg/dL (221 umol/L); - Mobile thrombus in the left ventricle; - Left Ventricle Ejection fraction < 10%; - Unstable angina; - Severe aortic stenosis - Primary severe mitral insufficiency; - New York Heart Association (NYHA) functional class IV; - Previous cardiac surgery or scheduled.

Study Design


Intervention

Procedure:
Bilateral sympathectomy
Bilateral sympathectomy will be performed using video assisted thoracoscopy using the Ethicon Ultracision device. The denervation consisted of left lower 1/3 stellate ganglion and T3- T4 thoracic interspinal space videothoracoscopic cutting, isolating the whole sympathetic chain between these two points using ultracision device on the nerve branches. The cephalic portion of the stellate ganglion was preserved to avoid Horner's syndrome and the electrocautery use was also avoided due to the same reason. The nerve was blocked using Ultracision device to avoid thermic lesion of the stellate ganglion. Hemodynamic and echocardiographic behaviors were continuously monitored during these surgical maneuvers.
Catheter ablation
Catheter ablation - patients allocated to this group will undergone epicardial and endocardial catheter ablation with the use of irrigated contact sensor tip catheter. Voltage electroanatomical mapping using Carto System will be performed in all cases and if hemodynamically stable VT is induced activation mapping will also be performed. The aim of the ablation is to eliminate the clinical VT additionally to substrate modification. The result of ablation will be defined as (1) complete success; (2) partial success and (3) failure.

Locations

Country Name City State
Brazil Heart Institute of Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo Sao Paulo

Sponsors (2)

Lead Sponsor Collaborator
University of Sao Paulo General Hospital Biosense Webster, Inc.

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time to Ventricular Tachycardia Recurrence Compare the time to the first documented Ventricular Tachycardia episode between groups 12 months
Primary Burden of Ventricular Tachycardia Recurrence Compare the number of Ventricular Tachycardia episodes between groups in 12 months 12 months
Secondary Ventricular Tachycardia Recurrence Following Sympathectomy Compared to Catheter Ablation. Time to first VT episode after sympathectomy compared to Catheter ablation 12 months
Secondary Mortality and Transplant Rate To compare between groups the number of patients who died or received a cardiac transplant at the end of the follow-up 12 months
Secondary Ventricular Ectopic Beats Density To evaluate the density of ventricular premature beats in the 24-hour Holter in the follow-up, for each group. 12 months
Secondary Length of Hospital Stay Compare the number of in-hospital days according to the type of intervention. 12 months
Secondary Rate of Complications Following Intervention Compare the rate of clinical complications according to the type of intervention. 12 months
Secondary Impact on Left Ventricular Ejection Fraction To evaluate the variations of the Left Ventricular Ejection Fraction in each group. 12 months
Secondary Autonomic Measures To compare the RR variability measures in the 24h-Holter between groups 12 months
See also
  Status Clinical Trial Phase
Completed NCT05791032 - Sub Chronic Evaluation for ATP With an Extravascular Placed ICD Lead (STEP ICD) Study N/A
Not yet recruiting NCT06063811 - Ventricular Tachycardia Ablation in LVAD Patients
Withdrawn NCT05049720 - ExtraVascular Implantable Cardiac Defibrillator Continued Access Study N/A
Completed NCT04060680 - Extravascular ICD Pivotal Study N/A
Not yet recruiting NCT04990089 - VIVO European Observational Registry
Recruiting NCT05418036 - Safety Assessment for Sotalol Protocol in Outpatient Unit Phase 4
Recruiting NCT04264455 - Evaluation of Long-term Incidence of Ventricular Arrhythmias in Patients With Acute Myocarditis
Recruiting NCT03821051 - China Structural Ventricular Arrhythmias Registry
Recruiting NCT03880708 - China Inherited Ventricular Arrhythmias Registry
Recruiting NCT03041519 - Zero-fluoroscopic Ablation Versus Conventional Fluoroscopic Ablation for the Treatment of Ventricular Arrhythmias N/A
Completed NCT03204981 - Intramural Needle Ablation for the Treatment of Refractory Ventricular Arrhythmias N/A
Recruiting NCT05829993 - Development of an Artificial Intelligence Algorithm to Detect Pathological Repolarization Disorders on the ECG and the Risk of Ventricular Arrhythmias
Recruiting NCT05707637 - Bipolar Radio-frequency Ablation After Standard Unipolar Approach - Prospective Registry.
Completed NCT05357716 - Preliminary Research Evaluation for Ambulatory Leadless Electrocardiogram Recorder Trial
Recruiting NCT06158698 - CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine Phase 3
Active, not recruiting NCT03495297 - A Randomised Trial of S-ICD Implantation With and Without Defibrillation Testing N/A
Recruiting NCT06378996 - Arrhythmic Mitral Valve Prolapse Detection Using Long-term Ambulatory Rhythm Monitoring N/A
Not yet recruiting NCT06360939 - Radiotherapy vs Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease N/A
Suspended NCT03502499 - Half-normal Saline in Idiopathic Left Ventricular Outflow Tract Arrhythmias Ablation N/A
Completed NCT04809701 - Non-vascular ICD Electrode Configuration Feasibility Study N/A